United States Patent (19) 11 Patent Number: 6,020,310 Beck Et Al
Total Page:16
File Type:pdf, Size:1020Kb
US00602031 OA United States Patent (19) 11 Patent Number: 6,020,310 Beck et al. (45) Date of Patent: Feb. 1, 2000 54 METHOD FOR ASSISTING IN Fara, Madden, “Effect of secretin and cholecystokinin on DIFFERENTIAL DIAGNOSIS AND small intestinal blood flow distribution,” Am. J. Physiology, TREATMENT OF AUTISTC SYNDROMES 1975; 229(5):1365–70. Dollinger, Berz, Raptis, von Uexkill, Goebell, “Effects of 75 Inventors: Victoria Beck, Bedford, N.H.; Karoly Secretin and Cholecystokinin on Motor Activity of Human Horvath, Baltimore, Md. Jejunum, Digestion 12:1975, pp. 9-16. Horvath, Stefanatos,Sokolski, Wachtel, Nabors, Tildon, 73 Assignee: Repligen Corporation, Needham, “Improved Social and language skills after Secretin admin Mass. istration in patients with autistic Spectrum disorders”, J. ASSOc. for Academic Minority Physicians 9(1):1998, pp. 21 Appl. No.: 09/080,631 9-15. Raymond, Bauman, Kemper, “Hippocampus in autism: a 22 Filed: May 19, 1998 Golgi analysis”, Acta Neuropathologica, 1996; 91(1): 117-9. Charlton, O'Donohue, Miller, Jacobowitz, "Secretin immu Related U.S. Application Data noreactivity in rat and pig brain', Peptides, 1981; 2 Suppl 60 Provisional application No. 60/047,049, May 19, 1997. 1:45-9. Fremeau, Korman, Moody, “Secretin stimulates cyclic AMP (51) Int. Cl." ..................................................... A61K 38/00 formation in the rat brain”, Journal of Neurochemistry, 52 U.S. Cl. ................................... 514/12; 514/2; 436/63; 1986; 46(6):1947–55. 436/86; 436/87; 424/198.1 Fremeau, Jensen, Charlton, Miller, O'Donohue, Moody, 58 Field of Search .................................. 436/63, 86, 87, “Secretin: specific binding to rat brain membranes”,Journal 436/501; 424/1841, 198.1, 514/2-21, 254 of Neuroscience, 1983; 3(8):162-05. Kimura, Mitsugi, Arita, Akema, Yoshida, “Effects of preop 56) References Cited tic injections of gastrin, cholecystokinin, Secretin, vasoac tive intestinal peptide and PHI on the secretion of luteinizing U.S. PATENT DOCUMENTS hormone and prolactin in Ovariectomized estrogen-primed 3,940,480 2/1976 Seunaga .................................... 514/12 rats”, Brain Research, 1987; 410(2):315–22. 3,987,014 10/1976 Guiducci ... 525/54.11 Bauman, Kemper, “Histoanatomic observations of the brain 4,086.220 4/1978 Schlatter ... ... 530/309 in early infantile autism”, Neurology, 1985; 35(6):866–74. 4,098,779 7/1978 König. ... 530/309 Minshew, “In vivo brain chemistry of autism”, magnetic 4,302,448 11/1981 Bickel ......................................, 514/12 4,533,494 8/1985 Uchiyama . ... 530/309 resonance spectroscopy studies in The Neurology of 4,711,847 12/1987 König ............ ... 435/68.1 Autisum, Bauman and Kemper (editors), The Johns Hopkins 4,778,794 10/1988 Naruse et al. ... ... 514/254 Press, Baltimore, 1994, 1994:66-85. 4,806,336 2/1989 Carlquist et al. ......................... 435/22 Baumann, Kemper, “Neuroanatomic observations of the 4,920,122 4/1990 Naruse et al. ... ... 514/254 brain in autism” in The Neurobiology of Autism, Bauman 4,994,467 2/1991 Zimmerman . ... 514/284 and Kemper (editors), The Johns Hopkins Press, Baltimore, 5,008,251 4/1991 Gruber ...................................... 514/43 1994, 1994:119-45. 5,094.837 3/1992 Bis ................ ... 424/9.34 Hoon, Reiss, “The mesial-temporal lobe and autism: case 5,225,407 7/1993 Oakley et al. .......................... 514/215 report and review” Review, Developmental Medicine & 5,527,825 6/1996 Karson et al. .......................... 514/551 Child Neurology, 1992; 34(3):252–9. 5,686,311 11/1997 Shaw ......................................... 436/86 Bachevalier, Meranian, “The contribution of medial tem FOREIGN PATENT DOCUMENTS poral lobe Structures in infantile autism: a neurobehavioral study in primates', in The Neurobiology of Autism, Bauman WO 98/52593 11/1998 WIPO. and Kemper (editors), The Johns Hopkins Press, Baltimore, OTHER PUBLICATIONS 1994, 1994:146-69. Schopler, Reichler, DeVellis, Daly, “Toward Objective Clas (List continued on next page.) sification of Childhood Austism: Childhood Autism Rating Scale (CARS)”, J. of Autism & Dev. Disorders 10(1):1980, Primary Examiner Maureen M. Wallenhorst pp. 91–103. Attorney, Agent, or Firm Fish & Richardson P.C. Karelson, Laasik, Sillard, "Regulation of Adenylate Cyclase 57 ABSTRACT by Galanin, Neuropeitide Y, Secretin and Vasoactive Intes tinal Polypeptide in Rat Frontal Cortex.Hippocampus and A novel relationship between pancreatico-biliary Secretion Hypothalamus', Neuropeptides 28;1995, pp. 21-28. and autistic Syndrome is disclosed. This relationship enables van Calker, Miller, Hamprecht, “Regulation by secretin, a novel therapy for the treatment of the Symptoms of autistic vasoactive intestinal peptide, and Somatostatin of cyclic Syndromes, comprising the administration of a therapeuti AMP accumulation in cultured brain cells', Proc. Natl. cally effective, preferably intravenous, dose of Secretin to an Acad. Sci. USA 77(11):1980, pp. 6907–6911. individual with autistic syndrome. The relationship further McGill, Basavappa, Gettys, Fitz, “Secretin activates enables a differential diagnosis for autistic Syndrome, com C1 channels in bile duct epithelial cells through a cAMP dependent mechanism”, Am. J. Physiology, 1994; prising an analysis of an individual’s blood and/or intestinal 266:C731-6. tissue for the presence of Secretin and comparison of the Leiter, Chey, Kopin, “Secretin”, Gut peptides. Biochemistry level of Secretin to known norms. and Physiology edited by Walsh and Dockray, Raven Press, Ltd., New York, 1994: 147-93. 28 Claims, 8 Drawing Sheets 6,020,310 Page 2 OTHER PUBLICATIONS Horvath et al., “Improved Social and Language Skills After Secretin Administration in Patients with Autistic Spectrum Dawson, Klinger, Panagiotides, Lewy, Castelloe, "Sub Disorders”, J. ASSOc. Acad. Minority Physicians, 9(1):9-15, groups of autistic children based on Social behavior display (1998). distinct patterns of brain activity”, Journal of Abnormal Piven, “The Biological Basis of Autism”, Curr. Op. Neuro Child Psychology, 1995; 23(5):569-83. biol. 7:708–712, (1997). George, Costa, Kouris, Ring, Ell, “Cerebral blood flow Rapin et al., “Neurobiology of Autism”, Annals of Neurol abnormalities in adults with infantile autism”, Journal of ogy, 43:7–14, (1998). Nervous & Mental Disease, 1992; 180(7):413-7. Ritvo et al., “A Medical Model of Autism: Etiology, Pathol Olsson, Steffenburg, Gilberg, “Epilepsy in autism and autis ogy and Treatment”, Pediatric Annals, 13(4):298–305, ticlike conditions: a population-based Study', Archives of (1984). Neurology, 1988; 45(6):666-8. Wickelgren, “Tracking Insulin to the Mind', Science, 280:517-518, (1998). Anderson, Freedman, Cohen, et al., “Whole blood serotonin Wing, “The Autistic Spectrum', The Lancet, 350:1761–66, in autistic and normal subjects”, J. Child Psychology & (1997). Psychiatry & Allied Disciplines, 1987; 28(6):885–900. Beck, “Transdermal Secretin and Our Approach,” (letter to Garnier, Comoy, Barthelemy, et al., “Dopamine-beta-hy www.healthboards.com/autism/1089.html) droxylase (DBH) and homovanillic acid (HVA) in autistic SECRETIN-TALKGONELIST.COM (Dec. 30, 1998). children”, J. Autism & Developmental Disorders, 1988; Rimland, Autism Research Review International, Jan. 1999 16(1):23–9. Update, Autism Research Institute (www.autism.com/ari/ Bouvard, Leboyer, Launay, et al., “Low-dose naltrexone secretin2.html) (Jan. 1999). effects on plasma chemistries and clinical Symptoms in Rimland, “Secretin update: Dec. 1, 1998, Autism Research autism: a double-blind, placebo-controlled study”, Psychia Review International, Autisum Research Institute (www.au try Research, 1995; 58(3):191-201. tism.com/ari/secretin2.html) (Dec. 1, 1998). El-Salihy, Abou-el-Ela, Falkmer, Grimelius, Wilander, Rimland, “1998 Year-End Letter,” Autism Research Insti “Immunohistochemical evidence of gastro-entero-pancre tute (www.autism.com/ari/yearend.html) (Nov. 30, 1998). atic neurohormonal peptides of Vertebrate type in the ner Binstock, Secretin, email to newsgroup bit...listserV.autism Vous System of the larva of a dipteran insect, the Hoverfly, (Aug. 23, 1996). EriStalis Aeneus', Regulatory Peptides 1:1980, pp. Mayberry, Secretin, email to newsgroup bit...listserV.autism 187-204. (Aug. 23, 1996). Westland, Secretin, email to newsgroup bit...listserv.autism McDougle, Price, Volkmar, “Recent advances in the phar (Aug. 24, 1996). macotherapy of autism and related conditions”, Child & Timpson, Secretin, email to newsgroup bit...listserv.autism Adolescent Psych. Clinics of N. Am., 1994; 3(1):71-89. (Aug. 24, 1996). Patel, Kong, Sreedharan, “Molecular cloning and expression Conaty, Secretin, email to newsgroup bit...listserv.autism of a human secretin receptor, Molecular Pharmacology, (Aug. 25, 1996). 1995; 47(3):467–73. Conaty, Pancreatic Lipase deficiency, email to newsgroup Lenzen, Alpini, Tavoloni, “Secretin Stimulates bile ductular bit...listserv.autism (Aug. 26, 1996). secretory activity through the cAMP system”, American Mayberry, Secretin, email to newsgroup bit...listserV.autism Journal of Physiology, 1992; 263(4 pt 1):G527–32. (Sep. 10, 1996). Pollack, Wood, Solomon, “Effect of secretin on growth of Mayberry, Canadian listmates, email to newsgroup bit...list Stomach, Small intestine, and pancreas of developing rats', serv.autism (Sep. 20, 1996). Digestive Diseases & Sciences, 1990; 35(6):749–58. Binstock, Secretin, email to newsgroup bit...listserV.autism Lebenthal, Clark, “Immunoglobin concentrations in the (Sep. 26, 1996). duodenal